Evidence map›Paper›PMID 41079359›Full record

ArticleFrontiers in neurology2025

Application of algorithms based on improved YOLO in MRI image detection of brain tumors.

Jinghui Chen, Tao Yang, Lianxin Xie, Lanlan Yang, Hongjia Zhao

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinghui Chen *The First Clinical Medical College, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Tao Yang *The First Clinical Medical College, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Lianxin XieThe First Clinical Medical College, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Lanlan YangThe First Clinical Medical College, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Hongjia ZhaoThe Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors, characterized by irregular cell growth in the brain or surrounding tissues, encompass aggressive types like glioblastoma and more indolent forms such as meningiomas and pituitary tumors, often leading to increased intracranial pressure, neurological dysfunction, and low survival rates despite multimodal treatment. Early and precise identification of tumor subtypes in MRI images remains challenging due to image noise, heterogeneity, and morphological variability, limiting real-time clinical diagnostics. To address these issues, we propose an improved YOLO11n model for brain tumor detection, incorporating lightweight GhostConv modules for reduced redundancy, Online Convolutional Reparameterization (OREPA) in the C3k2 module for enhanced efficiency, and Efficient Multi-scale Attention (EMA) for better multiscale feature capture. Using 4,000 annotated MRI images from a public Kaggle dataset (glioma, meningioma, pituitary tumor, and no tumor), divided into training, validation, and test sets (8:1:1 ratio), the model was trained over 200 epochs and evaluated on internal and external sets. The optimized model achieved a mean average precision (mAP@50) of 97.2% and recall of 93.8%, surpassing the baseline YOLO11n by 2.1% in mAP@50 while reducing GFLOPS by 25% from 6.4 to 4.8, demonstrating superior accuracy, efficiency, and lightweight design for edge deployment. This approach not only facilitates rapid tumor localization and classification in clinical practice but also supports personalized treatment planning, offering extensible solutions for broader medical imaging applications and improved patient outcomes.

Indexed as

artificial intelligencebrain tumormagnetic resonancetarget detectionYOLO11n

Identifiers

PMID41079359
PMCPMC12510949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.